Therapeutic use of selective synthetic ligands for retinoic acid receptors: a patent review
{{output}}
Introduction: Differentiation therapy using all-trans retinoic acid (ATRA) revolutionised the treatment of acute promyelocytic leukaemia to such an extent that it is now one of the most curable types of leukaemia, with ATRA and a... ...
